CBX3 Antibody

What is CBX3 and what are its key biological functions?

CBX3, also known as Heterochromatin Protein 1 gamma (HP1γ), is a highly conserved heterochromatin-associated non-histone chromosomal protein with critical nuclear functions. It is involved in transcriptional silencing in heterochromatin-like complexes and recognizes histone H3 tails methylated at 'Lys-9', leading to epigenetic repression . CBX3 contributes to multiple nuclear processes including gene activation/repression, regulation of cohesion complex binding to centromeres, sequestration of genes to the nuclear periphery, and heterochromatin formation and propagation .

The protein appears to contribute to heterochromatin association with the inner nuclear membrane through interaction with lamin B receptor (LBR) and participates in functional kinetochore formation by interacting with MIS12 complex proteins . Moreover, CBX3 mediates the recruitment of methyltransferases SUV39H1/SUV39H2 to circadian target genes and facilitates NIPBL recruitment to DNA double-strand breaks .

What applications are CBX3 antibodies commonly used for?

CBX3 antibodies support multiple experimental applications for investigating this important nuclear protein:

These applications enable researchers to investigate CBX3 expression, localization, protein interactions, and roles in chromatin regulation and nuclear organization.

What species reactivity can I expect from commercially available CBX3 antibodies?

Based on product information from multiple suppliers, commercially available CBX3 antibodies demonstrate the following species reactivity:

This reactivity pattern reflects the high conservation of CBX3 across mammalian species . When designing experiments with less common model organisms, sequence homology analysis and preliminary validation studies are advisable.

How do I select the appropriate CBX3 antibody for my experiment?

Selecting the appropriate CBX3 antibody requires consideration of several critical factors:

• Experimental application: Verify the antibody has been validated for your specific application (WB, IHC, ICC/IF, etc.)

• Species reactivity: Ensure compatibility with your experimental species - human, mouse, and rat are commonly supported

• Antibody type: Consider monoclonal antibodies (like Proteintech's 66446-1-Ig) for high specificity to a single epitope versus polyclonal antibodies which may offer higher sensitivity but potentially more background

• Validation data: Review manufacturer's validation images, positive control samples, and application-specific performance data

• Immunogen information: Check the immunogen sequence, especially if investigating specific domains of CBX3 (e.g., Sigma's antibody HPA004902 uses a specific sequence "RVVNGKVEYFLKWKGFTDAD...")

• Format requirements: Determine whether an unconjugated antibody or one conjugated to a reporter molecule better suits your detection method

For optimal results, cross-reference performance data from multiple vendors and consider pilot experiments with small quantities of antibody before committing to larger purchases.

What is the expected molecular weight of CBX3 in Western blot applications?

In Western blot applications, CBX3 typically appears at approximately 21-22 kDa . According to Proteintech's product information, the calculated molecular weight is 21 kDa, while the observed molecular weight is approximately 22 kDa . This minor discrepancy is common and can be attributed to post-translational modifications or inherent protein properties affecting SDS-PAGE migration.

When performing Western blot analysis, researchers should anticipate a distinct band around 22 kDa, though variations may occur depending on cell/tissue type, extraction methods, and gel conditions . As noted by Elabscience, "The actual band is not consistent with the expectation. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size." Post-translational modifications like phosphorylation may result in slight shifts in apparent molecular weight.

How can I optimize CBX3 antibody dilutions for different experimental applications?

Optimizing antibody dilutions is crucial for achieving specific signal while minimizing background. For CBX3 antibodies, recommended dilutions vary significantly across applications:

For optimal results, perform a dilution series experiment:

• Prepare a range of antibody dilutions (e.g., 1:500, 1:1,000, 1:2,000, 1:5,000 for WB)

• Run identical samples for each dilution

• Select the dilution providing the best signal-to-noise ratio

Optimal dilution may vary based on protein expression level, detection method (chemiluminescence vs. fluorescence), and incubation conditions. For Proteintech's CBX3 antibody (66446-1-Ig), Western blot recommendations range from 1:2,000-1:20,000, while ICC/IF ranges from 1:400-1:1,600 .

What are the recommended fixation and permeabilization methods for detecting CBX3 in immunofluorescence experiments?

For optimal CBX3 detection in immunofluorescence, proper fixation and permeabilization are critical as CBX3 is a nuclear protein associated with chromatin:

Recommended Fixation:

• Paraformaldehyde (PFA) fixation (4% PFA for 10-15 minutes at room temperature) preserves nuclear architecture while maintaining CBX3 antigenicity

• Avoid methanol fixation which can disrupt nuclear protein-protein interactions

Permeabilization Methods:

• Triton X-100 (0.1-0.5% for 5-10 minutes) is recommended for permeabilizing the nuclear membrane

• Alternative: 0.5% Saponin can be used for milder permeabilization

Bio-Techne specifically recommends "PFA/Triton X-100" as the fixation/permeabilization method for their CBX3 antibody in ICC/IF applications . This combination effectively preserves nuclear morphology while allowing antibody access to the nuclear compartment.

For optimal results:

• Fix cells with freshly prepared 4% PFA in PBS for 15 minutes at room temperature

• Wash 3× with PBS

• Permeabilize with 0.3% Triton X-100 in PBS for 10 minutes

• Proceed with blocking and antibody incubation

This protocol helps maintain CBX3's nuclear localization pattern, which typically shows nucleoplasmic staining with exclusion from constitutive heterochromatin .

How can I troubleshoot non-specific binding when using CBX3 antibodies in Western blot?

Non-specific binding in Western blot can complicate CBX3 detection. Consider these troubleshooting approaches:

Common Sources of Non-Specific Binding:

• Insufficient blocking: Extend blocking time (1-2 hours) or try alternative blocking agents (5% BSA, 5% non-fat dry milk)

• Antibody concentration too high: Dilute antibody further (e.g., 1:5,000 instead of 1:1,000)

• Cross-reactivity with similar proteins: CBX3 belongs to the chromobox family, which includes similar proteins (CBX1/HP1β, CBX5/HP1α)

• Sample preparation issues: Ensure complete protein denaturation and use fresh samples

Specific Troubleshooting Steps:

• Optimize antibody dilution: Use dilutions of 1:2,000-1:20,000 for Proteintech's antibody (66446-1-Ig) or 0.04-0.4 μg/mL for Sigma's antibody (HPA004902)

• Include appropriate controls:

  • Positive control: Cell lines known to express CBX3 (e.g., HeLa, NIH/3T3)

  • Negative control: Primary antibody omission

  • If available, CBX3 knockout/knockdown samples

• Modify washing conditions:

  • Increase washing duration (5× 5-minute washes)

  • Add 0.1% Tween-20 to wash buffer

• Use gradient gels: Due to CBX3's relatively small size (22 kDa), use higher percentage gels (12-15%) for better resolution

If multiple bands persist, verify against the expected molecular weight information. For CBX3, the primary band should appear at approximately 22 kDa , with potential additional bands representing post-translationally modified forms.

Why might the observed molecular weight of CBX3 differ from the calculated molecular weight?

The calculated molecular weight of CBX3 is approximately 21 kDa, but the observed molecular weight in Western blot is often around 22 kDa . According to Elabscience, "The actual band is not consistent with the expectation. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size."

Several factors can contribute to this discrepancy:

Post-translational Modifications (PTMs):

• Phosphorylation: Each phosphate group adds ~80 Da

• Other modifications: Methylation, acetylation, or ubiquitination can alter migration

Protein Structure and Composition:

• Hydrophobicity: Highly hydrophobic proteins may bind more SDS and migrate faster

• Acidic/basic residues: Unusually acidic or basic proteins may show anomalous migration

• Proline content: Proline-rich regions can cause kinks in the protein-SDS complex

Technical Factors:

• Gel percentage: Higher percentage gels may result in different apparent molecular weights

• Buffer systems: Tris-glycine vs. Tris-tricine systems can affect migration

• Reference markers: Variation between different molecular weight markers

Elabscience notes: "If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane." This suggests researchers may observe additional bands representing different post-translationally modified forms of CBX3.

What controls should I include when using CBX3 antibodies in research applications?

Including appropriate controls is essential for reliable interpretation of experiments using CBX3 antibodies:

Positive Controls:

• Cell lines known to express CBX3 (e.g., HeLa, NIH/3T3, Jurkat, HEK-293)

• Tissues with established CBX3 expression (e.g., human colon carcinoma, human placenta)

• Recombinant CBX3 protein (if available)

Negative Controls:

• Primary antibody omission: Use only secondary antibody to detect non-specific binding

• Isotype control: Use non-specific antibody of the same isotype (e.g., Mouse IgG2a for Proteintech's antibody)

• CBX3 knockdown/knockout samples (gold standard)

• Peptide competition: Pre-absorb antibody with immunizing peptide

Technical Controls:

• Loading control for Western blot (e.g., GAPDH, β-actin)

• Nuclear marker for colocalization in immunofluorescence (e.g., DAPI)

• Non-target proteins: Related proteins (CBX1/HP1β, CBX5/HP1α) to assess cross-reactivity

Application-Specific Controls:

• For Western blot: Molecular weight marker adjacent to samples

• For IHC/IF: Internal positive/negative cell populations

• For ChIP: Input sample, IgG control, positive/negative genomic regions

Implementing these controls helps ensure that observed signals are specific to CBX3 and not artifacts or non-specific binding, enhancing the reliability and reproducibility of research findings.

How do I validate the specificity of CBX3 antibodies in my experimental system?

Validating antibody specificity is critical for ensuring reliable research results. For CBX3 antibodies, consider these validation approaches:

Genetic Validation:

• siRNA/shRNA knockdown: Reduce CBX3 expression and confirm decreased signal by Western blot or immunofluorescence

• CRISPR/Cas9 knockout: Generate CBX3 knockout cells as the most stringent negative control

• Overexpression: Transfect cells with CBX3 expression vectors and confirm increased signal

Analytical Validation:

• Multiple antibodies: Use antibodies from different sources or against different epitopes of CBX3

• Peptide competition: Pre-incubate antibody with the immunizing peptide to block specific binding

• Mass spectrometry: Confirm the identity of immunoprecipitated proteins

Functional Validation:

• Subcellular localization: Confirm nuclear localization of CBX3 with particular enrichment in euchromatic regions

• Co-localization: Verify co-localization with known CBX3 interaction partners (e.g., H3K9me3)

• ChIP-seq comparison: Compare your ChIP-seq data with published datasets for CBX3/HP1γ

According to product information, Abcam's antibody (ab217999) has been validated using enhanced validation methodology, while Sigma's antibody (HPA004902) has undergone validation using orthogonal RNAseq approaches . These validation methods provide additional confidence in antibody specificity.

What are the best storage and handling practices for maintaining CBX3 antibody performance?

Proper storage and handling of CBX3 antibodies are essential for maintaining performance and extending usable lifespan:

Storage Temperature:

• Most CBX3 antibodies should be stored at -20°C for long-term storage

• Proteintech's CBX3 antibody (66446-1-PBS) specifically recommends -80°C storage

• Sigma's antibody (HPA004902) is shipped on wet ice but should be stored at -20°C

Aliquoting Recommendations:

• For antibodies in glycerol-containing buffers (like Sigma's HPA004902), aliquoting is generally unnecessary for -20°C storage

• For antibodies without glycerol (like Proteintech's 66446-1-PBS), create small single-use aliquots to avoid repeated freeze-thaw cycles

Buffer Considerations:

• Most CBX3 antibodies are supplied in PBS with stabilizers:

  • Sigma's antibody: Buffered aqueous glycerol solution

  • Proteintech's standard antibody: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3

  • Proteintech's PBS-only version: PBS without additives (requiring -80°C storage)

Freeze-Thaw Minimization:

• Limit freeze-thaw cycles to preserve antibody activity

• If frequent use is anticipated, keep a working aliquot at 4°C for up to 2 weeks

• Return antibody to appropriate storage temperature promptly after use

Handling Precautions:

• Centrifuge briefly before opening vials to collect liquid at the bottom

• Avoid contamination by using clean pipette tips

• Do not vortex antibodies; mix by gentle inversion or flicking

• Keep antibodies on ice when in use

Following these storage and handling practices will help maintain CBX3 antibody performance over time, ensuring consistent and reliable experimental results.